Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Bendamustine

An alkylating agent that combines a nitrogen mustard with a benzimidazole ring, synthesised in 1963 in Jena, East Germany: today it is used for chronic lymphocytic leukaemia, indolent non-Hodgkin lymphomas and multiple myeloma. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.

Did you know?For over twenty years it was used only in East Germany: systematic clinical trials began after German reunification, and it was approved in the United States in 2008.

BendamustineGo to the active ingredient →
BendamustineActive ingredientBendamustineCat. No. P-B027-001CAS 16506-27-7
HC Blue 1ImpurityHC Blue 1Cat. No. P-B027-070CAS 2784-94-3

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.